Fluxome and GlycaNova join forces to bring a promising beta glucan product to the US dietary supplement market
on 15/03/2010 18:44
Nutraceutical ingredient provider, Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS.
Read more
Read more

